Charles Rhyee
PersonRelationship Network
HOUSE_OVERSIGHT_024921.jpg
This document is page 105 of a 'Cowen Collaborative Insights' report dated February 25, 2019. It serves as a 'Points of Contact' directory listing the profiles, contact information, and coverage areas for eleven Cowen research analysts. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024921', indicating it was produced during a House Oversight Committee investigation.
HOUSE_OVERSIGHT_024885.jpg
A Cowen 'Collaborative Insights' financial research report dated February 25, 2019, authored by Chen. The document analyzes the market entry of Cannabidiol (CBD) into mass retail, predicting that the beauty sector (Luxury and Prestige) will adopt it before broadline retailers like Walmart or Target. It details specific moves by Barneys, Neiman Marcus, DSW, and Sephora. The document bears the Bates stamp HOUSE_OVERSIGHT_024885, indicating it was part of a document production to the House Oversight Committee, likely incidental to a larger financial investigation as no specific Epstein-related individuals are mentioned in the text.
HOUSE_OVERSIGHT_024880.jpg
This document is page 64 of a Cowen Collaborative Insights market research report dated February 25, 2019. It analyzes the healthcare payor and provider perspectives on CBD oils and medical marijuana, specifically discussing reimbursement challenges with CMS and commercial insurers, as well as policy shifts at Intermountain Healthcare in Utah. The document bears a 'HOUSE_OVERSIGHT_024880' Bates stamp, indicating it was part of a document production for a House Oversight Committee investigation.
HOUSE_OVERSIGHT_024879.jpg
This document is page 63 of a Cowen Collaborative Insights report dated February 25, 2019, authored by an analyst named Rhyee. It analyzes the market trends of CBD products in pharmacies, noting that independent pharmacies are adopting CBD sales faster than large chains like CVS or Walgreens due to high margins and demand. The report highlights that while Walgreens (WBA) does not sell CBD in the US, its UK subsidiary, Boots, does sell Dragonfly brand CBD oils, as illustrated by a website screenshot included in the report. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was produced during a congressional investigation.
HOUSE_OVERSIGHT_024823.jpg
This document is page 7 of a financial research report titled 'Cowen's Collective View of CBD,' dated February 25, 2019. It outlines the anticipated growth of the U.S. CBD market to $16 billion by 2025 and lists various analysts covering specific sectors such as consumer products, pharmacy, and regulation. The document bears a 'HOUSE_OVERSIGHT' stamp, indicating it was likely produced as part of a congressional investigation, possibly related to banking records, though the text itself contains no direct references to Jeffrey Epstein.
HOUSE_OVERSIGHT_024822.jpg
This document is the Table of Contents for a 'Cowen Collaborative Insights' research report dated February 25, 2019, focusing on the CBD and Cannabis market. The report covers various sectors including consumer products, healthcare, and global landscapes, with sections attributed to specific analysts (e.g., Azer, Nadeau, Schenkel). The document bears a 'HOUSE_OVERSIGHT_024822' Bates stamp, indicating it is part of a document production to the House Oversight Committee, likely related to investigations into financial records.
HOUSE_OVERSIGHT_024820.jpg
This document is page 4 of a Cowen 'Collaborative Insights' market research report dated February 25, 2019. It analyzes the market for cannabinoids (CBD), focusing on synthetic biology production methods, laboratory testing opportunities for life science companies, and the perspectives of drug retailers and insurance payors regarding coverage and sales. The document bears a 'HOUSE_OVERSIGHT_024820' Bates stamp, indicating it was part of a production to the House Oversight Committee, likely related to financial investigations.
HOUSE_OVERSIGHT_024819.jpg
A Cowen equity research report titled 'Cowen's Collective View of CBD - Ahead of the Curve Series,' dated February 25, 2019. The document analyzes the U.S. CBD market, projecting a $16 billion opportunity by 2025, and discusses consumer trends, scientific understanding, and hemp cultivation. The document bears a House Oversight Committee Bates stamp (HOUSE_OVERSIGHT_024819) and a watermark indicating it was intended for Michael Cella at Cowen.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity